ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 126 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $13,000 | +62.5% | 700 | 0.0% | 0.00% | – |
| Q2 2019 | $8,000 | -20.0% | 700 | 0.0% | 0.00% | – |
| Q1 2019 | $10,000 | +42.9% | 700 | 0.0% | 0.00% | – |
| Q4 2018 | $7,000 | -41.7% | 700 | 0.0% | 0.00% | – |
| Q3 2018 | $12,000 | +9.1% | 700 | 0.0% | 0.00% | – |
| Q2 2018 | $11,000 | +175.0% | 700 | +118.8% | 0.00% | – |
| Q1 2018 | $4,000 | -60.0% | 320 | -63.2% | 0.00% | – |
| Q4 2017 | $10,000 | +233.3% | 870 | +222.2% | 0.00% | – |
| Q3 2017 | $3,000 | -70.0% | 270 | -69.0% | 0.00% | – |
| Q2 2017 | $10,000 | +42.9% | 870 | +171.9% | 0.00% | – |
| Q1 2017 | $7,000 | -41.7% | 320 | -46.7% | 0.00% | – |
| Q4 2016 | $12,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,203 | $36,042,000 | 9.93% |
| Foresite Capital Management II, LLC | 1,043,832 | $12,787,000 | 5.18% |
| Redmile Group, LLC | 6,476,766 | $79,340,000 | 3.91% |
| DAFNA Capital Management LLC | 346,013 | $4,239,000 | 2.63% |
| Cormorant Asset Management, LP | 900,000 | $11,025,000 | 1.95% |
| SENZAR ASSET MANAGEMENT, LLC | 641,170 | $7,854,000 | 1.92% |
| Asymmetry Capital Management, L.P. | 105,228 | $1,289,000 | 1.50% |
| New Leaf Venture Partners, L.L.C. | 171,364 | $2,099,000 | 0.97% |
| EMERALD ADVISERS, LLC | 1,578,477 | $19,336,000 | 0.79% |
| BB BIOTECH AG | 2,266,008 | $27,759,000 | 0.77% |